The Challenge
Exponent's client is developing chimeric antigen receptor (CAR) T-cell therapy, a promising treatment for multiple myeloma and non-Hodgkin's lymphoma. However, a potentially life-threatening immune system side-effect — cytokine release syndrome (CRS) — requires monitoring those receiving CAR T-cell therapy in the hospital, which increases healthcare system costs and negatively impacts patients' quality of life.
EXPONENT'S MULTIDISCIPLINARY SOLUTION
Based on the depth of experience in Exponent's Health Sciences, Biomedical Engineering & Sciences, and Biomechanics practices, a client asked us to identify digital health technologies for effective at-home monitoring of CRS and other potential side effects of CAR T-cell therapy.
EXPONENT'S IMPACT
The client incorporated Exponent's insights for monitoring CAR T-cell therapy recipients using digital health technologies to streamline the treatment process and reduce hospitalizations, improving affordability, equitable access, and outcomes.
What Can We Help You Solve?
We help our life sciences clients thrive by bringing data-driven and evidence-based approaches to pushing the boundaries of what's possible in patient care. Connecting decades of experience across industries, we stay agile and evolve our capabilities to see around corners, anticipate challenges, and mitigate them for our clients.
Medical Device Design & Development Support
Crucial medical device design and development analyses to empower your decision-making.
Medical Technology Assessment Program
Rapid, expert assessments of medical devices and technologies. surgical implants, and wearable medical technologies.
Medical Device Evaluation
Sophisticated medical device evaluations for a vast array of applications.
Next-Gen Wearables in Healthcare
Effectively demonstrate the clinical, experiential, and economic value of wearable devices.
Multidisciplinary Expertise to Support the Life Sciences Industry
Support for next-gen medical devices, wearable technologies, and pharmaceutical products.
Healthcare & Life Sciences Value & Outcomes Assessment
Strategic guidance for medical product value and access, including drugs, vaccines, and medical devices.